FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children

[cafead]

via The US Food and Drug Administration (FDA) has granted approval for Sanofi and Regeneron’s Dupixent (dupilumab) to treat moderate-to-severe atopic dermatitis in children aged six months to five years.

article source